Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Tranexamic Acid in Nasal Mohs Local Flap Reconstruction
NCT06057675Phase 2Recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- Mar 2024
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of tranexamic acid in Postoperative bleeding, ecchymosis and edema (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoints: Surgical site swelling and bruising assessed by surgeon at 1 week, Surgical site swelling and bruising assessed by patient at 1 week and 1 more. Started Mar 2024; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
Postoperative bleedingecchymosisedema
Beyond the preview
Go deeper on NCT06057675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06057675.